Ardevora Asset Management’s Quest Diagnostics DGX Stock Holding History

Ardevora Asset Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-396,268	Closed	-$33M	–	115
2018 Q4	$33M	Buy	396,268 +59,100	+18%	+$5.54M	0.99%	54
2018 Q3	$36.4M	Buy	337,168 +15,465	+5%	+$1.7M	1.01%	22
2018 Q2	$35.4M	Sell	321,703 -31,532	-9%	-$3.28M	0.99%	17
2018 Q1	$35.4M	Buy	353,235 +835	+0.2%	+$85.5K	1.06%	44
2017 Q4	$34.7M	Sell	352,400 -30,300	-8%	-$2.87M	1.04%	53
2017 Q3	$35.8M	Buy	382,700 +14,900	+4%	+$1.58M	1.07%	35
2017 Q2	$40.9M	Buy	367,800 +334,900	+1,018%	+$35.4M	1.29%	5
2017 Q1	$3.23M	Buy	+32,900	New	+$3.14M	0.11%	109

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ardevora Asset Management's DGX Position: Q1 2019 in Review

Ardevora Asset Management sold out of Quest Diagnostics (DGX) in Q1 2019, closing a stake of 396,268 shares — an estimated $33M sold.

Ardevora Asset Management first reported a position in DGX in Q1 2017 and held it in 8 quarters. The position peaked at $40.9M in Q2 2017. 656 funds tracked by Wall St. Rank hold DGX as of Q1 2019.

Ardevora Asset Management reported no remaining Quest Diagnostics position as of Q1 2019 after selling out during the quarter.
Ardevora Asset Management sold 396,268 Quest Diagnostics shares in Q1 2019, an estimated $33M.
Ardevora Asset Management first reported a position in Quest Diagnostics in Q1 2017 and held it in 8 quarters.
Ardevora Asset Management's Quest Diagnostics position peaked at $40.9M in Q2 2017.
656 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2019.

Based on Ardevora Asset Management's 13F filing for Q1 2019, filed 24 Apr 2019.